Stratistics MRC Announces Its New Report, "Stents - Global Market Outlook (2015-2022)"

Gaithersburg, MD, February 17, 2016 --(PR.com)-- According to Stratistics MRC, the Global Stents Market is valued at $8.43 billion in 2015 and is projected to grow to $12.13 billion by 2022 growing at a Compound Annual Growth Rate of 5.3%. Rising adoption of drug-eluting stents as a more efficient treatment for coronary heart disease, coupled with growing awareness among patients about stents, is anticipated to fuel the market growth. On the other hand strict regulations for approval of stents, abridged reimbursement and substitute methods and are hampering the market. The innovation of technological advanced products with lower re-stenosis occurrence rates such as bio-absorbable stents and the existence of high unmet medical needs in emerging Asian countries are some of the future growth opportunities of this market.

Bare metal stents segment anticipated to have a turn down in revenue during the forecast period. Bio-absorbable stents segment is estimated to witness the highest CAGR during the forecast period. By Application, urological stents segment dominates the market and accounts for more than 50% market share. The global stent market is mostly controlled by three players Abbott Laboratories, Medtronic and Boston Scientific. However, small and medium companies from Asia and Europe have a significant share in terms of volume in developing economies.
Some of the key players in the market are Medtronic, Abbott Laboratories, Arterius, B. Braun, Biosensors International, Biotronik, Boston Scientific Corp., C.R. Bard Inc., Celonova Biosciences, Cook Medical, Cordis Corp., Covidien, Elixir Medical Corp., Inspiremd and Kyoto Me.

Device Covered:
• Drug-Eluting Stents
• Bioresorbable Stents
• Bare-Metal Stents
• Others
o Plastic Stents
o Self Expanding metal Stents
Application Covered:
• Vascular stents
o Coronary Stents
o Peripheral stents
o Peripheral Lower-Extremity Arterial Stents Gastrointestinal Stents
o Iliac Artery Stents
o Neurovascular Stents
§ Carotid Stents
§ Intracranial stents
o Renal Artery Stents
• Non-vascular stents
• Urology
o Prostate stents
o Ureteral & Urethral stents
• Ophthalmology
• Gastrointestinal
o Colorectal
o Duodenal stents
o Esophageal
o Pancreatic & Biliary
• Airway
• Others
Materials Covered:
• Polymers
o Bio-absorbable polymers
o Durable polymer
• Metals
o Nickel-titanium
o Cobalt-chromium
o Stainless steel
o Platinum-chromium
o Others
Coatings Covered:
• Coated stents
o Inorganic
o Polymer
o Polymer-free
o Other coated stents
• Non-coated stents
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

For more info, kindly visit http://strategymrc.com/report/stents-market or write to them at info@strategymrc.com.